Recent Lessons

Show all results for ""

Feature Overview

Ace your exams with our all-in-one platform for creating and sharing quizzes and tests.

Quizzes

Create quizzes and tests automatically from your content using AI.

Flashcards

Automatically turn your notes into digital flashcards.

Share, Export & Embed

Share with classmates or export to Excel and your learning management system.

Stats & Reporting

Auto-grading quizzes and tests with detailed stats and reports.

Mobile Apps

The smarter way to study – wherever you are.

Pricing

Search...

5 Questions

4 Views

CLL Prognosis and Survival

Choose a study mode

Play Quiz

Study Flashcards

Spaced Repetition

Chat to lesson

Podcast

Play an AI-generated podcast conversation about this lesson

Questions and Answers

What is the median survival period for patients with CLL?

5 years

20 years

2 years

10 years (correct)

What is the significance of lymphocyte doubling time in CLL?

It is a prognostic factor of CLL (correct)

It is a diagnostic factor of CLL

It is a treatment factor of CLL

It is a curative factor of CLL

What is lymphocyte doubling time defined as?

The number of months it takes to double the absolute lymphocyte count (correct)

The number of months it takes to triple the absolute lymphocyte count

The number of months it takes to halve the absolute lymphocyte count

The number of months it takes to quadruple the absolute lymphocyte count

Patients with CLL who present as Rai stage 0-II may survive for how long without treatment?

<p>5 to 20 years</p> Signup and view all the answers

What is the characteristic of CLL in untreated patients with a lymphocyte doubling time of less than 6 months?

<p>A more aggressive expression</p> Signup and view all the answers

Study Notes

Chronic Lymphocytic Leukemia (CLL) Survival

Survival for patients with CLL can vary significantly, ranging from 2 to over 20 years.
The median survival rate for CLL patients is approximately 10 years.
Patients diagnosed at Rai stage 0-II have a favorable prognosis, potentially surviving between 5 to 20 years without treatment.

Prognostic Factors

Lymphocyte doubling time serves as a crucial prognostic factor in CLL.
This measure indicates the months required for the absolute lymphocyte count to double.
Untreated patients exhibiting a shorter lymphocyte doubling time tend to have a more aggressive form of CLL.

Studying That Suits You

Use AI to generate personalized quizzes and flashcards to suit your learning preferences.

Description

Learn about the survival period and prognosis of patients with Chronic Lymphocytic Leukemia (CLL), including factors that affect survival rates and treatment options.